Apellis Pharmaceuticals shares owned by Bleakley Financial Group
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Bleakley Financial Group
from 13F filings
Historical chart of Bleakley Financial Group investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Bleakley Financial Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $2.3M | 74k | 31.91 |
| 2024-09-30 | $2.3M | 79k | 28.84 |
| 2024-06-30 | $3.0M | 79k | 38.36 |
| 2024-03-31 | $4.6M | 78k | 58.78 |
| 2023-12-31 | $4.7M | 78k | 59.86 |
| 2023-09-30 | $3.0M | 78k | 38.04 |
| 2023-06-30 | $7.2M | 79k | 91.10 |
| 2023-03-31 | $12M | 182k | 65.96 |
| 2022-12-31 | $9.4M | 182k | 51.71 |